Image via PRN — Economy & Policy
Abbott: Ma Activity
Abbott completed acquisition of Exact Sciences, establishing itself as a leader in the fast-growing oncology diagnostics market
Source: PRN — Economy & Policy
The leadership read
Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in medtech.
Market context: Backdrop: a 98.4 (Neutral) Talent Market Index (down 1.6 on the month) with Americas activity easing (-2.7pts).
Abbott: 2 signals in the last 90 days — above the MedTech median of 1 across 18 tracked companies; 0.2% of MitchelLake's Americas signal flow; 3 tracked across 83 days.
MitchelLake in this thematic
Our work · 2022
Head of eCommerce and Consumer Experience (CX) / GM North America
LittleOak
Americas · Ecommerce · cross-border · ecommerce-growth
Our work · 2019
VP of Sales, Americas
Longtail UX
Americas · MarTech/SEO/SEM · first us hire · cross border
Our work · 2019
VP Sales (US) / CEO
Multiple (Longtail UX, Genbook)
Americas · Technology/SaaS · founder-transition · international-expansion
Also at Abbott →
More signals across MedTech
Ma Activity · Americas
Analog Devices →In talks to acquire Empower Semiconductor for $1.5 billion, focusing on AI chip power management
Ma Activity · Americas
Boston Scientific →Boston Scientific invested $1.5bn to acquire a 34% equity stake in MiRus, an implants and procedural solutions developer
Product Launch · Americas
Medtronic →Medtronic received FDA 510(k) clearance in June 2026 for its Nellcor pulse oximetry system with Nell-EQ intelligent processor. Product designed to improve oxygen saturation and pulse rate monitoring accuracy across diverse skin tones and care settings, aligned with new ISO 80601-2-61:2026 standards.
Capital Raising · Americas
Perimeter Medical Imaging AI, Inc. →Perimeter Medical Imaging AI filed Form D for private placement, indicating capital raising activity
Product Launch · Americas
Illumina →Illumina launched fireflyGO automation platform in partnership with SPT Labtech, designed to accelerate targeted oncology research
Product Launch · Americas
Caris Life Sciences →Caris Life Sciences submitted application to NY State Department of Health for Caris Assure Blood-Based Testing Authorization, expanding their precision medicine offerings
Intelligence powered by Autonodal ↗